Deeptech startup Acculi Labs raised $1.5 M fresh funding from Sabi Holding
Deep-tech life growth solutions provider Acculi Labs has raised $1.5 million in a fresh investment round led by Sabi Holding India Ltd., valued at $25 million.
The Bengaluru-based business had previously raised Rs 5 crore in 2020 during a seed funding round that was directed by PirE Ventures.
According to a press release from Acculi Labs, the new fund will be used to boost workforce, operational effectiveness, infrastructure development, and the speed at which its conscious AI insights systems are developed.
Acculi Labs, co-founded in May 2017 by Rupam Das and Hari Prasath M, aims to provide patients with access to home-based care. Lyfas, the company’s flagship product, helps early-stage asymptomatic patients see their doctor sooner by facilitating simple, routine early diagnostics and monitoring.
Acculi Labs claims that with the introduction of Lyfas, its product line grew from a single cardiac health assessment system to a full range of healthcare solutions.The platform states that it can obtain psychophysiological biomarkers non-invasively with its mobile application and provide a comprehensive health report in three minutes.
The business created Lyra, a cutting-edge artificial intelligence (AI) that can communicate with both silicon and carbon-based life forms. Additionally, Lyfas Udyam, an initiative that offers small business owners a micro-enterprise circular economy to start and run their enterprises by utilizing the ecosystem, procedures, and funding, has been launched.
